Transcatheter Interventions in Adult Congenital Heart Disease.

Autor:	Blais BA; Cardiac Catheterization & Interventional Therapies, The Heart Center, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA; Department of Pediatrics, The Ohio State University College of Medicine, 370 W Ninth Avenue, Columbus, OH 43210, USA. Electronic address: Benjamin.Blais@NationwideChildrens.org., Marshall WH 5th; Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, 410 W. Tenth Avenue, Columbus, OH 43210, USA; The Heart Center, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA., Wadia S; Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, 410 W. Tenth Avenue, Columbus, OH 43210, USA; The Heart Center, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA., Armstrong AK; Cardiac Catheterization & Interventional Therapies, The Heart Center, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA; Department of Pediatrics, The Ohio State University College of Medicine, 370 W Ninth Avenue, Columbus, OH 43210, USA., Daniels C; The Heart Center, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA; Department of Internal Medicine, Division of Cardiovascular Medicine, Adult Congenital Heart Disease Program and Pulmonary Hypertension Program, The Ohio State University Wexner Medical Center, 410 W. Tenth Avenue, Columbus, OH 43210, USA.
Jazyk:	angličtina
Zdroj:	Interventional cardiology clinics [Interv Cardiol Clin] 2024 Jul; Vol. 13 (3), pp. 385-398. Date of Electronic Publication: 2024 Apr 08.
DOI:	10.1016/j.iccl.2024.03.004
Abstrakt:	Congenital heart disease (CHD) is the most common congenital birth defect with an incidence of 1 in 100. Current survival to adulthood is expected in 9 out of 10 children with severe CHD as the diagnostic, interventional, and surgical success improves. The adult CHD (ACHD) population is increasingly diverse, reflecting the broad spectrum of CHD and evolution of surgical techniques to improve survival. Similarly, transcatheter interventions have seen exponential growth and creativity to reduce the need for repeat sternotomies. This article focuses on newer data and evolving techniques for transcatheter interventions specific to certain ACHD populations. Competing Interests: Disclosure A.K. Armstrong: Consultant: Abbott, Edwards Lifesciences, Medtronic, Inc., Cook Medical, Starlight Cardiovascular, B. Braun Interventional Systems Inc.; Research Support: Edwards Lifesciences, United States, Renata Medical, at Heart Medical LLC. C.J. Daniels, MD Consultant: Edwards Lifesciences, Medtronic, Inc. (Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu